Multiple infections with different HCV genotypes: Prevalence and clinical impact

Journal of Clinical Virology

Volumn 27, Issue 2, 2003, Pages 200-204

  Schröter, Matthias ^a   Feucht, Heinz Hubert ^a   Zöllner, Bernhard ^a   Schäfer, Peter ^a   Laufs, Rainer ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antiviral therapy; Hepatitis C virus; Infection

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAMPLING; SCREENING; SEROLOGY; SERUM; SUPERINFECTION; VIREMIA; VIRUS STRAIN; VIRUS TYPING;

CROSS-SECTIONAL STUDIES; EPIDEMIOLOGY, MOLECULAR; GERMANY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; SEROTYPING;

EID: 18144449593     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00264-0     Document Type: Article

References (12)

1. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., Kaslow R.A., Margolis H.S. Prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:1999;556-562.
2. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina Selby R., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;2451-2455.
3. Mehta S.H., Cox A., Hoover D.R., Wang X.H., Mao Q., Ray S., Strathdee S.A., Vlahov D., Thomas D.L. Protection against persistence of hepatitis C. Lancet. 359:2002;1478-1483.
4. Proust B., Dubois F., Bacq Y., Le Pogam S., Rogez S., Levillain R., Goudeau A. Two successive hepatitis C virus infections in an intravenous drug user. J. Clin. Microbiol. 38:2000;3125-3127.
5. Schreiber M., Petersen H., Wachsmuth C., Müller H., Hufert F.T., Schmitz H. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectiuos and not of infectious virions present in autologous serum. J. Virol. 68:1994;3908-3916.
6. Schröter M., Feucht H.H., Schäfer P., Zöllner B., Laufs R. Serological determination of Hepatitis C Virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay. J. Clin. Microbiol. 37:1999;2576-2580.
7. Schröter M., Zöllner B., Schäfer P., Laufs R., Feucht H.H. Quantitative detection of HCV RNA by Light Cycler™ PCR: comparison with two different PCR assays. J. Clin. Microbiol. 39:2001;765-768.
8. Schröter M., Zöllner B., Schäfer P., Laufs R., Feucht H.H. Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays. J. Clin. Virol. 23:2001;57-63.
9. Schröter M., Zöllner B., Schäfer P., Reimer A., Müller M., Laufs R., Feucht H.H. Epidemiological dynamics of HCV among 747 German individuals: new subtypes on the advance. J. Clin. Microbiol. 40:2002;1866-1868.
10. Simmonds P., Alberti A., Alter H.J., Bonino F., Bradley D.W., Brechot C., Brouwer J.T., Chan S.W., Chayama K., Chen D.S., Choo Q.L., Colombo M., Cuypers H.T.N., Date T., Duskeiko G.M., Esteban J.I., Fay O., Hadziyannis S.J., Han J., Hatzakis A., Holmes E.C., Hotta H., Houghton M., Irvine D., Kohara M., Kolberg J.A., Kuo G., Lau J.Y.N., Lelie P.N., Maertens G., McOmish F., Miyamura T., Mizokami M., Nomoto A., Prince A.M., Reesink H.W., Rice C.M., Roggendorf M., Schalm S.W., Shikata T., Shimotohno K., Stuyver L., Trepo C., Weiner A., Yap P.L., Urdea M.S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 19:1994;1321-1324.
11. Widell A., Mansson S., Persson N.H., Thysell H., Hermodsson S., Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation. 60:1995;642-647.
12. Zeuzem S., Feinmann S.V., Rasenack J., Heathcote E.J., Lai M.Y., Gane E., O'Grady J., Reichen J., Diago M., Lin A., Hoffman J., Brunda M.J. Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med. 343:2000;1723-1724.